- Opin vísindi
- →
- Browsing by Subject
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Subject "Lyfjafræðingar"
Now showing items 1-8 of 8
-
(2024-03-28)OBJECTIVES: To determine the prevalence and incidence of polypharmacy/hyperpolypharmacy and which medications are most prescribed to patients with varying burden of polypharmacy. DESIGN: Retrospective, population-based cohort study. SETTING: Iceland. ... -
(2023-01-01)OBJECTIVES: To evaluate the access to comprehensive diagnostics and novel antituberculosis medicines in European countries. METHODS: We investigated the access to genotypic and phenotypic Mycobacterium tuberculosis drug susceptibility testing and the ...
-
(2021-03)TILGANGUR Langtímaárangur efnaskiptaaðgerða hjá einstaklingum með offitu er almennt góður, með tilliti til þyngdartaps, fylgisjúkdóma offitu og lífsgæða. Hins vegar geta aðgerðirnar aukið líkur á næringarefnaskorti. Markmið rannsóknarinnar var að kanna ...
-
(2022-06-16)Background: Cardiomyopathy is a known complication of organic acidemias but generally thought to be secondary to poor metabolic control. Methods: Our patient was found through biochemical testing and Sanger sequencing to harbor an Icelandic founder ...
-
(2023-05-05)Background: The aim of this study was to determine the prevalence of preoperative polypharmacy and the incidence of postoperative polypharmacy/hyper-polypharmacy in surgical patients and their association with adverse outcomes. Methods: This was a ...
-
(MDPI AG, 2017-04-26)Even though pharmaceutical care is not a new concept in pharmacy, its introduction and development has proved to be challenging. In Iceland, general practitioners are not familiar with pharmaceutical care and additionally no such service is offered in ...
-
(2023-05-05)Ágrip INNGANGUR Notkun prótónpumpuhemla (PPH) hefur aukist á undanförnum áratugum. Hluti sjúklinga er á lyfjunum án ábendingar. Mögulegt er að ný notkun hefjist í kjölfar skurðaðgerða. Markmið rannsóknarinnar var að skoða nýgengi notkunar PPH í kjölfar ...
-
(2023-10-01)BackgroundEuropean-specific policies for tuberculosis (TB) elimination require identification of key populations that benefit from TB screening.AimWe aimed to identify groups of foreign-born individuals residing in European countries that benefit most ...
Now showing items 1-8 of 8